The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
20 Staniford Street
Boston, MA 02114-2500
The Schepens Eye Research Institute (SERI) a non-profit organization, is a prominent center for research on the eye, vision, and blinding diseases. Established in 1950 and an affiliate of the Department of Ophthalmology at Harvard Medical School, the Schepens Eye Research Institute is dedicated to research that improves the understanding, management, and prevention of eye diseases and visual deficiencies; fosters collaboration among its faculty members; trains young scientists and clinicians from around the world; promotes communication with scientists in allied fields; and is a leader in the worldwide dispersion of basic scientific knowledge of vision. The Schepens Eye Research Institute's research program focuses on eye studies and the search for causes of disease in several core areas, including retinal and macular diseases (macular degeneration and diabetic retinopathy), corneal and ocular surface diseases (dry eye syndrome and corneal infection and injury), anterior segment diseases (glaucoma), ocular immunology (ocular cancer, inflammation, viral infections), transplantation (retinal and corneal transplants), and low vision aids and diagnostic technologies. The Schepens Eye Research Institute provides a variety of materials including brochures, reports and a magazine.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.